Hi-tech Pharmacal Co, Inc. (HITK) Tops Q2 EPS by 27c, Sales Exceed Expectations
Tweet
Share
E-mailGet Alerts HITK Hot Sheet
Price: $43.49 --0%
Financial Fact:
DILUTED INCOME PER SHARE: 0.59
Today's EPS Names:
OTLK, EGRX, MOVE, More
Financial Fact:
DILUTED INCOME PER SHARE: 0.59
Today's EPS Names:
OTLK, EGRX, MOVE, More
Join SI Premium – FREE
Hi-tech Pharmacal Co, Inc. (NASDAQ: HITK) reported Q2 EPS of $1.04, $0.27 better than the analyst estimate of $0.77. Revenue for the quarter came in at $56.88 million versus the consensus estimate of $51.4 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Prosensa Holding N.V. (RNA) Reports Q2 Loss of $1.18
- Edible Garden AG (EDBL) Reports Q2 Loss of $18.79
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
